HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 6 X posts from 3 X users, with an upper bound of 21,961 followers.

RT @sitcancer: #JITC Research: HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expres…

#JITC Research: HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1 https://t.co/81R4FhrpXP https://t.co/8fWqRbgnuX

#JITC Research: HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1 https://t.co/81R4FhrpXP https://t.co/nYQ9tKna4Z

#JITC Research: HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1 https://t.co/81R4FhrpXP https://t.co/8O9IQh1vTy

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.